NDC 0008-2001-01 - Protonix I.V.
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0008-2001
- Requested NDC
- 0008-2001-01
- Package NDCs from labels
- 0008-2001-01, 0008-2001-25, 0008-2001-10
- Manufacturer
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Takeda GmbH | Pharmacia & Upjohn Company LLC
- Effective date
- 2022-05-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PANTOPRAZOLE SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Takeda GmbH | Pharmacia & Upjohn Company LLC | 2022-05-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0008-2001-01 | EA - Each | 0008-2001 | ad389b07-7de3-422f-b0ff-7201c7e3a0c0 | 1 | 2014-04-03 |
| 0008-2001-10 | EA - Each | 0008-2001 | bda3bf5d-8674-4692-b11d-f8e080e04d1c | 1 | 2014-04-03 |
| 0008-2001-25 | EA - Each | 0008-2001 | 5d5925d0-ec2a-4b9a-aa1c-c0909dde694b | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PANTOPRAZOLE SODIUM | ACTIVE INGREDIENT | 6871619Q5X | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| PANTOPRAZOLE | ACTIVE MOIETY | D8TST4O562 | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | NorthStar Rx LLC | 6637d90b-b268-4a5f-ab5b-885f2d5f0d4b | 2026-02-06 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Burel Pharmaceuticals, LLC | 3cc5197e-6b39-4415-b963-d4bbeecd7953 | 2026-02-06 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Torrent Pharmaceuticals Limited | 9c983da1-a8e0-479e-8816-5d5668ea242e | 2026-02-05 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | Camber Pharmaceuticals, Inc. | 9daa1483-5a36-44db-9e0d-904d100da262 | 2026-01-22 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Cardinal Health 107, LLC | 6229247e-ee15-466e-a8ac-adcd646b738d | 2026-01-22 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | Quallent Pharmaceuticals Health LLC | 643eb498-d916-4fb7-9281-32895575ab36 | 2026-01-13 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | AvPAK | dcac4022-fea1-67c5-3331-fefcc3c440d8 | 2026-01-09 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Major Pharmaceuticals | de419aa0-caa9-40fb-bc6d-e341c94273c7 | 2026-01-08 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | Northwind Health Company, LLC | da67e1c0-9947-957d-e053-2a95a90ad96d | 2026-01-01 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Northwind Health Company, LLC | f2a1af50-a051-3e55-e053-2a95a90a9184 | 2026-01-01 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Northwind Health Company, LLC | d9deb251-96d3-5f96-e053-2a95a90a0792 | 2026-01-01 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Cardinal Health 107, LLC | 410d5577-e50a-44f3-aaa8-fbf391a0c261 | 2025-12-30 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Chartwell RX, LLC | 42a969c3-1144-4151-9cf3-3e9bace6a380 | 2025-12-22 | Warnings, Adverse reactions | 6871619Q5X |
| Protonix I.V. | PANTOPRAZOLE SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 51e4144a-489e-436c-609a-39305f8f56ba | 2025-12-22 | Warnings, Adverse reactions | NDA020988 6871619Q5X |
| Protonix I.V. | PANTOPRAZOLE SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | f39b3e7d-39d2-4c8a-9974-4ab885241880 | 2025-12-22 | Warnings, Adverse reactions | NDA020988 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | QPharma Inc | b4a94a37-47c1-4dd9-9e4d-5b4a03480aa6 | 2025-12-04 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | AvPAK | b9fa8381-b75e-b1cd-e053-2a95a90a9883 | 2025-12-03 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | QPharma Inc | fbd035d0-529c-6033-e053-6294a90abf07 | 2025-12-02 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole sodium | PANTOPRAZOLE SODIUM | Ajanta Pharma USA Inc. | 90963a38-f629-45a4-bddd-9e13a55fe0f7 | 2025-11-26 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE | PHOENIX RX LLC | 440b9ae8-2fb8-5d35-e063-6294a90a82b6 | 2025-11-20 | Warnings, Adverse reactions | 6871619Q5X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.